NOTCH3 and oral cavity squamous cell carcinoma: These results demonstrate the pro-angiogenic functionality of NOTCH3+CAFs in oral squamous cell carcinoma providing therapeutic opportunities either by the targeting of these CAFs alone or in combination with existing angiogenesis inhibitors.